MedTrace Logo

Comparing Inhalation and Total Intravenous Anesthesia Methods

NCT06467279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-02-03

No results posted yet for this study

Summary

This study compares the effects of anesthesia using target-controlled infusion (TCI) and inhalation methods on pediatric patients undergoing inguinal hernia repair. The main outcomes include intraoperative hemodynamic stability and postoperative recovery characteristics. Sixty children were randomized to receive either total intravenous anesthesia (TIVA) via the Eleveld model or inhalation anesthesia with sevoflurane. The study aims to evaluate which method is safer and more effective in pediatric surgical anesthesia.

Conditions

  • Children
  • Hernia, Inguinal

Interventions

DEVICE

Target Controlled İnfusion

TCI (Target-Controlled Infusion) is a method used to maintain the dose and rate of anesthesia drugs within a target concentration range set by the anesthetist. This system delivers drugs intravenously to the patient using a computer-controlled pump. The anesthetist adjusts the drug concentration to achieve the desired depth of anesthesia. This method provides more precise control over anesthesia and facilitates maintaining the depth of anesthesia within the desired range.

DRUG

Inhalation anesthetic

In the inhalation anesthesia group, maintenance sevoflurane anesthesia will be applied after routine induction.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Özlem OZ GERGİN, MD · TC Erciyes University

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-15
Primary Completion
2023-12-15
Completion
2023-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06467279 on ClinicalTrials.gov